Literature DB >> 1003006

Effect of sulfones on complement deposition in dermatitis herpetiformis and on complement-mediated guinea-pig reactions.

S I Katz, K C Hertz, P S Crawford, L A Gazze, M M Frank, T J Lawley.   

Abstract

The role of complement and the mechanism of sulfone action in dermatitis herpetiformis (DH) have not yet been established; prior studies have presented conflicting data regarding the effect of sulfones on complement activation and deposition. Thirty-eight DH patients were studied. Twenty-four of 25 perilesional skin biopsies and 50 of 67 normal-appearing skin biopsies showed the third component of complement (C3) deposited in areas corresponding to those of IgA deposition. Nine of 10 patients with bound C3 in normal-appearing and perilesional skin during periods of active disease continued to have C3 in normal-appearing skin when treatment with sulfones kept them completely free of lesions for 2 to 8 weeks. When either Hartley-strain or C4-deficient guinea pigs were given up to 150 mg/kg sulfoxone (a water-soluble sulfone) intraperitoneally for 8 days before elicitation of active Arthus, reverse passive Arthrus reactions, or Forssman shock, there was no difference in time course, character, or intensity of reactions when compared to saline-treated control animals. We were therefore unable to demonstrate any effect of sulfones on complement deposition in DH skin or on complement activation in classical or alternate complement pathway-mediated guinea-pig reactions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1003006     DOI: 10.1111/1523-1747.ep12598565

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Thrombocytopenia in systemic lupus erythematosus responsive to dapsone.

Authors:  C Moss; P J Hamilton
Journal:  BMJ       Date:  1988-07-23

Review 3.  Dermatitis herpetiformis.

Authors:  R P Hall; T J Lawley; S I Katz
Journal:  Springer Semin Immunopathol       Date:  1981-06

Review 4.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

5.  The anti-inflammatory profile of dapsone in animal models of inflammation.

Authors:  A J Lewis; D K Gemmell; W H Stimson
Journal:  Agents Actions       Date:  1978-12

6.  Dermatitis herpetiformis: effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity.

Authors:  J A Kazmierowski; J E Ross; D S Peizner; K D Wuepper
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

7.  Comparative effects of drugs on four paw oedema models in the rat.

Authors:  D K Gemmell; J Cottney; A J Lewis
Journal:  Agents Actions       Date:  1979-04

Review 8.  Cutaneous manifestations in celiac disease.

Authors:  L Abenavoli; I Proietti; L Leggio; A Ferrulli; L Vonghia; R Capizzi; M Rotoli; P L Amerio; G Gasbarrini; G Addolorato
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

9.  IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.

Authors:  R P Hall; T J Lawley; J A Heck; S I Katz
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

10.  Effects of dapsone on passive Arthus reaction and chemotaxis and phagocytosis of polymorphonuclear leukocytes.

Authors:  T Ruzicka; A Bauer; S Glück; M Born
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.